@twpainter live at #ASM22PER acknowledging the huge contribution of @ctn_anzca & @POISE3_ANZ to the #POISE3 trial. Thank you to all of the site contributors #whatateam! @gillyormo @katy_skier @ealmaxwell @davimcall @AlliKearney
POISE-3 Australia and New Zealand
@POISE3_ANZ
An international RCT of tranexamic acid and hypotension avoidance for bleeding and vascular events after noncardiac surgery.
344 Following 361 Followers 371 Posts
Latest posts 5
NZ & Australian POISE-3 sites- tune into @twpainter presenting TxA results of @PHRIresearch #POISE3 trial shortly! @ctn_anzca Late Breaking Trials Sessions at #ASM22PER @ANZCA @katy_skier
Thank you 馃檹馃徎馃檹馃徎馃檹馃徎 @PeterMacCC @pahospital @SEastSydHealth @western_health @Akld_DHB @Austin_Health @easternhealthau @MonashHealth @WAHealth @HNEHealth
A huge thank you to our @ANZCA CTN sites across Aus & NZ who made the #POISE3 #RCT3 a success! A special thank you to our dedicated research coordinators! @POISE3_ANZ @twpainter @katy_skier @ealmaxwellhard @PHRIresearch #ACC22View quoted post on X
@AlliKearney @gillyormo @nhmrc @ACTAcommunity
@POISE3_ANZ was only made possible due to the amazing the contribution of our dedicated @ctn_anzca sites. Thank you 馃檹馃徎 @NEJM @NHMRC @twpainter @katy_skier @ealmaxwellhard @PHRIresearch #ACC22 @AlliKearney @gillyormo @ACTAcommunity @CritCareUniMelb
Amazing achievement! #POISE3 #TxA results now published in @NEJM Clear benefit shown for the use of TxA in non cardiac surgery in reducing bleeding! #ACC22
Among patients undergoing noncardiac surgery, the incidence of the composite bleeding outcome was significantly lower with tranexamic acid than with placebo. #ACC22 nej.md/3IMTKozView quoted post on X